(12-361) Incidence and Management of Hypersensitivity Reactions to Liposomal Doxorubicin

Wednesday, December 10, 2025

2:00 PM - 3:00 PM

Location: Bayside A, Level 1

Residency Program: Hospital of the University of Pennsylvania
Residency Program Type: PGY2 (Oncology Pharmacy)
Residency Program Location: Pennsylvania

Co-Author(s): Desiree Croteau, Rachel Hatch, Kristin Melathe

Primary Author(s)

Luor Doeibis, PharmD, RPh

PGY-2 Pharmacy Oncology Resident
The Hospital of the University of Pennsylvania